News for Charles River Laboratories International, Inc. (RV6.DE)

We came across a bullish thesis on Charles River Laboratories International, Inc. (CRL) on scuttleblurb’s Substack. In this article, we will summarize the bulls’ thesis on CRL.

On May 23, Redburn Atlantic turned bullish on Charles River Laboratories International, Inc. (NYSE:CRL) as it upgraded its stock from “Neutral” to “Buy,” despite marginally reducing the price objective to $182 from $188. The upgrade was seen off the back of an improvement in demand in Charles River Laboratories International, Inc. (NYSE:CRL)’s Discovery and Safety […]

Charles River Laboratories International, Inc. (CRL) has announced an extension to the employment agreement of its Chair, President, and Chief Executive Offic

On May 23, 2025, Redburn Atlantic, a prominent financial analyst firm, issued an update on Charles River (CRL), a well-known company listed on the NYSE. Jamie C

An analyst at Redburn Atlantic has highlighted Charles River Laboratories (CRL) as a stock with promising growth potential through 2025. Unlike Iqvia Holdings,

Ginkgo Bioworks has announced a leadership transition with its CFO, Mark Dmytruk, planning to leave the company on May 30 to pursue a new opportunity. In respon

Shares of Charles River Laboratories International Inc (CRL) fell 3.98% in mid-day trading on May 21. The stock reached an intraday low of $137.82, down from

On May 15, 2025, George Massaro, a Director at Charles River Laboratories International Inc (CRL), sold 140 shares of the company. Following this transaction, t

On May 14, 2025, George Massaro, a Director at Charles River Laboratories International Inc (CRL), sold 140 shares of the company. Following this transaction, t

TD Cowen has raised its rating on Charles River (CRL) from Hold to Buy, increasing the price target to $179, up from $105. The firm sees potential value creatio

Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2025 Results Conference Call May 7, 2025 9:00 AM ETCompany ParticipantsTodd Spencer - Vice...

U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Wednesday. Shares of Rockwell Automation, Inc. ROK rose sharply during Wednesday...

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that four new directors will join its Board of Directors and that four long-time mem

The U.S. stock market staged a stunning one-month rebound, fully erasing the losses triggered by Donald Trump‘s April 2 tariff announcements. From its April ...

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the initial cohort of its Charles River Incubator Program (CIP). [url="]Launched in

Upslope Capital Management, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The First quarter was challenging for the fund. However, the world has transformed in the two weeks since March 31, due to a drastic realignment of international trade rules. As a result, markets […]

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide […]

Baird analyst Eric Coldwell has increased the price target for Charles River Laboratories (CRL) to $118, up from a previous target of $101. Despite this upward

Summary Charles River Laboratories International Inc (CRL) has announced that it will release its first-quarter 2025 financial results on Wednesday, May 7th, be